ATG-F

ApprovedCompleted

0 watching 0 views this week🔥 Hot

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

✓

Phase 3

Approved

Indication / Disease

De Novo Kidney Transplant Patients

Conditions

De Novo Kidney Transplant Patients

Trial Timeline

Jul 31, 2012 → Dec 31, 2015

NCT ID

NCT02267512

About ATG-F

ATG-F is a approved stage product being developed by Astellas Pharma for De Novo Kidney Transplant Patients. The current trial status is completed. This product is registered under clinical trial identifier NCT02267512. Target conditions include De Novo Kidney Transplant Patients.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT02267512	Approved	Completed	Jul 31, 2012	Dec 31, 2015	De Novo Kidney Transplant Patients

Competing Products

19 competing products in De Novo Kidney Transplant Patients

See all competitors

Product	Company	Stage	Hype Score
Alefacept + placebo + Tacrolimus + Mycophenolate Mofetil + Steroids	Astellas Pharma	Phase 2	52
Tacrolimus targeted half-dose + Tacrolimus targeted plain dose	Astellas Pharma	Approved	85
Prograf + Advagraf	Astellas Pharma	Approved	85
Advagraf + Prograf + Corticosteroid + Mycophenolate mofetil	Astellas Pharma	Approved	85
Tacrolimus targeted half-dose + Tacrolimus targeted plain dose	Astellas Pharma	Approved	85
Venetoclax + Azacitidine + Cytarabine + Methotrexate + Hydrocortisone + Leucovorin + Dexamethasone + Vincristine + Doxorubicin + Dexrazoxane + Calaspargase Pegol + Erwinia asparaginase	AbbVie	Phase 1	33
Birabresib Dose 20 mg	Merck	Phase 1	33
Enteric-coated Mycophenolate sodium (EC-MPS)	Novartis	Phase 3	77
Enteric-coated Mycophenolate sodium (EC-MPS)	Novartis	Approved	85
Enteric-Coated Mycophenolate Sodium (EC-MPS)	Novartis	Approved	85
everolimus + cyclosporine + Prednison (continuous steroids)	Novartis	Phase 3	77
Enteric-coated Mycophenolate sodium (EC-MPS)	Novartis	Phase 3	77
AEB071	Novartis	Phase 1	33
Enteric-Coated Mycophenolate Sodium	Novartis	Phase 3	77
EC-MPS	Novartis	Phase 3	77
Enteric-coated Mycophenolate sodium (EC-MPS), valsartan	Novartis	Phase 3	77
everolimus	Novartis	Phase 3	77
Prograf + Tacrolimus Hexal	Novartis	Approved	85
Mycophenolate Mofetil	Roche	Approved	85

Other Products from Astellas Pharma

Tacrolimus, Prograf®Approved

micafungin + voriconazoleApproved

mirabegron + solifenacinApproved

Zolpidem (Myslee®) + placeboApproved

TacrolimusApproved